Pre-market: Vical Inc. receives $6 million grant
Shares of Vical Inc. (Nasdaq: VICL) are sagging despite news this morning that the San Diego-based pharmaceutical company has been awarded a three-year, $6 million grant from the National Institute of Allergy and Infectious Diseases (NIAID) for a DNA vaccine manufacturing process. Shares are down $0.05, or 1%, to $4.95.
Shares of Repligen Corp. (Nasdaq: RGEN) are trading higher following news this morning that the Waltham, Mass.-based pharmaceutical company has received a favorable ruling from the U.S. District Court for the District of Massachusetts on a patent infringement lawsuit involving ImClone Systems Inc. (Nasdaq: IMCL).
Shares of Repligen Corp. (Nasdaq: RGEN) are trading higher following news this morning that the Waltham, Mass.-based pharmaceutical company has received a favorable ruling from the U.S. District Court for the District of Massachusetts on a patent infringement lawsuit involving ImClone Systems Inc. (Nasdaq: IMCL).
For access to the full article, you must be a registered member - it's FREE.
Already a member? Please log in below
Not Registered?
Register today and enjoy all that SmallCapInvestor.com has to offer, including:
- Daily small cap stock profiles.
- Intra-day coverage of Russell 2000 companies.
- Research and insights from our analysts.
- Special reports.
